Organo <6368>: 7810 yen (+1000 yen).

Hitting the daily limit up. It released financial results for the first half of last week, with operating profit at 11.5 billion yen, a 46.1% increase from the same period last year, exceeding the previous estimate of 9.5 billion yen. The full-year forecast has been raised from the previous 24.5 billion yen to 28 billion yen, a 24.2% increase from the previous year, following an upward revision at the time of the first quarter results. The annual dividend has also been increased from the original plan of 106 yen to 142 yen, a 40 yen increase from the previous period. The significant increase in sales in the relatively profitable solution business seems to be the main reason for the profit increase.

DMG Mori Seiki <6141>: 2616 yen (-324.5 yen).

Significant continued decline. It announced third quarter financial results the day before, with first half operating profit at 23.2 billion yen, a 2.9% increase from the same period last year, while the period from July to September recorded 6.79 billion yen, a sharp 48.0% decrease. The full-year forecast has been revised downward from the previous 58.5 billion yen to 44 billion yen, an 18.7% decrease from the previous year. The full-year consensus was around 57 billion yen. Additionally, it also published performance outlook for the fiscal year ending in 2025. Operating profit is expected to increase by double digits to 49 billion yen, but it is seen as significantly below the previous forecast for the current period, leading to a negative outlook.

Yamaha <7951>: 1074 yen (-171.5 yen).

Significant drop. It released second quarter financial results last weekend, with operating profit for July to September at 2.8 billion yen, a 68.7% decrease from the same period last year, significantly lower than the market expectation of around 1.1 billion yen. The impairment of production facilities at overseas factories (about 7.8 billion yen) is the background. Furthermore, the full-year forecast has been downwardly revised from the previous 44.5 billion yen to 27 billion yen, a 6.9% decrease from the previous year, reversing to an expected decline in profits. The consensus was likely around 40 billion yen. It appears that there has been a significant downward revision in the musical instrument business.

Nitto Bose <3110>: 6000 yen (-1400 yen).

Significant continued decline. It announced financial results for the first half last weekend, with operating profit reaching 7.35 billion yen, a 2.4-fold increase from the same period last year, exceeding the upward revision to 7 billion yen made at the time of the first quarter results. The full-year forecast of 15 billion yen, a 78.8% increase from the previous year, remains unchanged, but it has been decided to raise the annual dividend from 55 yen in the previous period to 87 yen. However, while operating profit was 3.91 billion yen in the first quarter, a 4.4-fold increase from the same period last year, it slowed down to 3.44 billion yen in the July-September period, a 54.0% increase, indicating a sense of near-term exhaustion.

FCC <7296>: 2865 yen, A buy indication.

Stop-limit buy sentiment. The company announced its second-quarter financial results last weekend, with an operating profit for July-September of 5.08 billion yen, a 47.5% increase from the same period last year, exceeding market expectations despite one-time expenses. The full-year estimate is 16 billion yen, a 5.9% increase from the previous year, with a strong potential for significant outperformance. In addition, the company announced an increase in annual dividends from the previous 76 yen to 202 yen as part of a commemorative dividend implementation, which will have a strong impact. They also announced a share buyback of up to 1.25 million shares and 2.5 billion yen.

Agyu <9330>: 802 yen (+5 yen)

Rebound. After the close of trading on the 1st, they announced a downward revision of the full-year forecast for the fiscal year ending September 24. They revised the revenue down to 1.56 billion yen (5.4% decrease) and the operating profit down to 0.001 billion yen (98.3% decrease). However, due to factors such as a large-scale project in the corporate support area that was expected in the fourth quarter being rescheduled to the next period and a reduction in project size, the operating profit is now expected to fall below the previous forecast. The downward revision is attributed to the delay in the large project, leading to a trend of buying due to the perceived opportunity.

Base Food <2936>: 475 yen (+28 yen)

Sharp rebound. It has been well received that Makoto Takashi, President and Representative Director of Melco Holdings, has increased his shareholding in the company, buying more shares. Mr. Takashi submitted a change report (5% Rule report) to the Ministry of Finance on November 1st. According to the report, Mr. Takashi's ownership ratio of Base Food shares increased from 29.05% to 30.19%. The reporting obligation date is November 1st.

3D Matrix <7777>: 110 yen (+3 yen)

Rebound. They announced a business partnership with Sumitomo Pharma International mainly related to the procurement and logistics of self-organizing peptide, a key raw material for hemostatic product. SPI will support global procurement of raw materials and product logistics for surgical hemostatic products developed using self-organizing peptide technology, strengthening the supply chain. As part of the business partnership, by utilizing the credit line set by SPI for them, it will be possible to apply longer payment terms than the current ones, improving the company's cash flow.